Molecular Method Market Report: Trends, Forecast and Competitive Analysis to 2031

The global molecular method market is expected to grow with a CAGR of 6.1% from 2025 to 2031. The major drivers for this market are the rising demand for personalized medicine and increased research in genomics and biotechnology.

The future of the global molecular method market looks promising with opportunities in the instrument, reagents & consumables, and services markets.

• The publisherl forecasts that, within the type category, polymerase chain reaction (PCR) is expected to witness the highest growth over the forecast period.
• Within the application category, reagents & consumables are expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Molecular Method Market

The molecular method market is evolving rapidly due to technological advancements and increasing applications in various industries. Several trends are reshaping the landscape, enhancing diagnostic capabilities, and expanding the scope of molecular methods.

• Integration of Artificial Intelligence (AI) in Molecular Diagnostics: AI is transforming molecular diagnostics by improving the accuracy of data analysis and interpretation. In combination with molecular techniques like PCR and NGS, AI algorithms can identify patterns in genetic data, which aids in diagnosing diseases such as cancer and genetic disorders more effectively. AI-driven solutions are also being used to improve the speed of testing and reduce human error, enabling healthcare providers to make more timely and accurate decisions. As AI technologies continue to evolve, they will play a significant role in revolutionizing molecular diagnostics.
• Expansion of Next-Generation Sequencing (NGS) Applications: NGS technologies are expanding beyond genetic research into clinical diagnostics, particularly in oncology, genetics, and rare diseases. NGS allows for more comprehensive and detailed genetic analysis, which enables precision medicine. The growing affordability and accessibility of NGS platforms are driving their use in clinical settings, facilitating early disease detection and personalized treatment plans. With the increasing volume of genetic data, NGS is becoming a key tool in molecular diagnostics and therapeutic decision-making.
• Point-of-Care Molecular Diagnostics: The demand for point-of-care (POC) molecular diagnostics has been rising, especially in response to the need for rapid, on-site testing during the COVID-19 pandemic. These portable devices enable immediate testing and results without requiring a laboratory setting, which is particularly valuable in rural or underserved areas. POC molecular diagnostics are being increasingly used in infectious disease detection, genetic testing, and monitoring of chronic conditions. The trend toward miniaturization of molecular diagnostic tools is likely to drive further growth in this area, making testing more accessible and efficient.
• Advancements in CRISPR Technology for Molecular Diagnostics: CRISPR gene-editing technology is revolutionizing molecular diagnostics by enabling more precise and efficient detection of specific genetic sequences. Researchers are developing CRISPR-based diagnostic tools that can quickly and accurately detect pathogens and genetic mutations. These advancements promise to improve early disease detection and offer potential solutions for personalized medicine. The integration of CRISPR into molecular diagnostics is a significant trend that could lead to faster and more affordable diagnostic tools, benefiting both healthcare and agriculture.
• Molecular Methods in Environmental Monitoring: The use of molecular methods in environmental monitoring is growing, with applications ranging from detecting pathogens in water to identifying pollutants in soil. PCR and NGS are being used to detect microbial contamination in water supplies, assess biodiversity, and monitor the spread of invasive species. These methods are improving environmental safety and sustainability, particularly as concerns about climate change and environmental degradation increase. The adoption of molecular methods in environmental sciences is expected to grow as governments and organizations focus on more effective environmental monitoring and management.

These emerging trends are reshaping the molecular methods market by driving innovation, improving accessibility, and expanding the scope of applications. AI integration, NGS expansion, point-of-care diagnostics, CRISPR advancements, and environmental monitoring are key trends that will continue to shape the market. As these technologies advance, they will unlock new opportunities for healthcare, agriculture, and environmental protection, transforming industries worldwide.

Recent Developments in the Molecular Method Market

Several key developments are influencing the molecular method market, with technological advancements and growing applications in diagnostics and research.

• Development of Rapid PCR Testing Platforms: Recent advancements in PCR technology have led to the development of faster and more accurate testing platforms. These platforms can deliver results in real-time, which is crucial for infectious disease diagnostics. The COVID-19 pandemic significantly accelerated the adoption of rapid PCR tests, and their application is now expanding to other infectious diseases and genetic testing.
• Advancements in CRISPR-based Diagnostic Tools: The development of CRISPR-based molecular diagnostic tools is a significant milestone in the market. These tools allow for rapid and accurate detection of genetic mutations and pathogens. CRISPR diagnostics can be done in a matter of hours, making them ideal for use in point-of-care settings and reducing diagnostic turnaround times in healthcare.
• Increased Use of NGS in Clinical Diagnostics: Next-generation sequencing (NGS) is expanding beyond research into clinical diagnostics, particularly in oncology and rare genetic disorders. NGS offers comprehensive genetic insights, enabling more personalized treatment plans. As the cost of NGS continues to decrease, it is expected to become a standard tool in clinical settings, improving diagnostic accuracy and treatment efficacy.
• Molecular Methods for Sustainable Agriculture: Molecular methods are increasingly being used to address challenges in agriculture, including disease detection, pest management, and genetic modification of crops. The development of molecular diagnostic tools for detecting plant pathogens is improving food security. Molecular methods are also being employed to create genetically modified crops that are more resistant to pests and diseases, contributing to sustainable agriculture.
• Advancements in Point-of-Care Diagnostic Devices: There has been a significant increase in the development of point-of-care (POC) molecular diagnostic devices, especially for infectious diseases. These portable and user-friendly devices enable on-site testing, eliminating the need for laboratory facilities. The growth of POC diagnostics is making molecular testing more accessible in rural and low-resource areas, improving global healthcare outcomes.

These key developments are shaping the molecular methods market by improving diagnostic speed, accuracy, and accessibility. Innovations in PCR, CRISPR, NGS, and point-of-care diagnostics are transforming healthcare and agriculture, making molecular methods more efficient and widely adopted.

Strategic Growth Opportunities in the Molecular Method Market

The molecular method market offers numerous growth opportunities across a variety of applications. As new technologies emerge, the potential for growth in healthcare, agriculture, and environmental monitoring expands.

• Cancer Diagnostics and Treatment: Molecular methods are playing a key role in cancer diagnosis and treatment, with technologies such as PCR, NGS, and CRISPR being used to identify genetic mutations and biomarkers specific to various cancers. These tools enable early detection, personalized treatment, and better monitoring of treatment efficacy. The continued development of molecular methods in oncology presents significant growth opportunities.
• Infectious Disease Detection and Monitoring: The demand for molecular methods in the detection and monitoring of infectious diseases has skyrocketed, particularly in response to the COVID-19 pandemic. PCR and other molecular techniques are becoming essential tools for diagnosing diseases like tuberculosis, HIV, and Zika virus. The growing need for rapid diagnostics and surveillance tools in infectious disease control offers significant market growth potential.
• Agricultural Biotechnology: Molecular methods are being increasingly used in agriculture for disease detection, pest management, and crop improvement. The development of genetically modified crops and more efficient pest control methods is driving the use of molecular diagnostics in the agricultural sector. This presents significant opportunities for growth in agricultural biotechnology, particularly in developing countries where food security is a priority.
• Personalized Medicine and Genomic Research: The move toward personalized medicine, where treatments are tailored to an individual’s genetic profile, is driving growth in genomic research and diagnostics. Molecular methods such as NGS and CRISPR-based technologies are enabling more accurate diagnoses and targeted therapies. This growing field presents significant growth opportunities for companies developing molecular diagnostic tools.
• Environmental Monitoring and Sustainability: As concerns about climate change and environmental degradation rise, molecular methods are being increasingly used for environmental monitoring. These methods help detect pollutants, monitor biodiversity, and track the spread of invasive species. The demand for molecular tools in environmental science and sustainability is expected to grow as environmental protection becomes a higher priority worldwide.

The molecular methods market offers strategic growth opportunities in various sectors, including healthcare, agriculture, and environmental monitoring. By focusing on applications such as cancer diagnostics, infectious disease detection, and sustainable agriculture, the molecular methods market is poised for continued expansion and innovation.

Molecular Method Market Driver and Challenges

The molecular methods market is influenced by technological, economic, and regulatory factors that drive growth and pose challenges.

The factors responsible for driving the molecular method market include:

• 1. Technological Advancements: Advances in molecular technologies like PCR, NGS, and CRISPR are driving the market by enabling more accurate and rapid diagnostics. These innovations enhance disease detection and treatment planning, particularly in oncology, infectious diseases, and genetics.
• 2. Increased Demand for Early Disease Detection: As healthcare systems prioritize early detection and prevention, molecular methods are in high demand. Technologies that enable early diagnosis of conditions like cancer, genetic disorders, and infectious diseases are seeing significant growth.
• 3. Personalized Medicine: Personalized medicine is driving the adoption of molecular methods by offering tailored treatment plans based on genetic and molecular profiles. Technologies like NGS and CRISPR are essential for delivering personalized therapies.
• 4. Expanding Applications in Agriculture: Molecular methods are increasingly being used in agriculture for pathogen detection, pest management, and the development of genetically modified crops. This shift toward molecular-based agriculture is driving growth in the sector.
• 5. Rising Healthcare Expenditure: Global increases in healthcare spending are contributing to the adoption of advanced diagnostic technologies, including molecular methods. As healthcare providers invest in state-of-the-art diagnostic tools, the market for molecular methods expands.

Challenges in the molecular method market are:

• 1. High Costs of Molecular Methods: The cost of advanced molecular methods, including PCR, NGS, and CRISPR, remains a barrier to adoption in many regions. High costs can limit access to these technologies, particularly in low-income areas.
• 2. Regulatory Hurdles: The complex and varied regulatory requirements across countries pose challenges for the market. Different approval processes for molecular diagnostic devices and treatments can delay product launches and market entry.
• 3. Limited Awareness and Education: In some regions, there is limited awareness of the benefits and capabilities of molecular methods. Educating healthcare professionals and the public about the value of these technologies is crucial to driving adoption.

The molecular methods market is driven by technological advancements, increased demand for early disease detection, and the rise of personalized medicine. However, challenges such as high costs, regulatory barriers, and limited awareness need to be addressed to unlock the full potential of the market. Overcoming these challenges will support the continued growth and widespread adoption of molecular methods.

List of Molecular Method Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies molecular method companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the molecular method companies profiled in this report include:

• Qiagen
• 3M
• Veredus Laboratories
• Neogen Corporation
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• BioMérieux
• Archerdx
• Himedia Laboratories
• Eurofins Scientific

Molecular Method Market by Segment

The study includes a forecast for the global molecular method market by type, application, and region.

Molecular Method Market by Type [Value from 2019 to 2031]:

• Polymerase Chain Reaction (PCR)
• Immunoassay
• Biosensors
• Microarray
• Other

Molecular Method Market by Application [Value from 2019 to 2031]:

• Instrument
• Reagents & Consumables
• Services

Molecular Method Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Molecular Method Market

The molecular methods market has seen significant advancements in recent years due to innovations in diagnostic tools, biotechnology, and research methodologies. These techniques are pivotal in numerous sectors, including healthcare, agriculture, and environmental science. As the demand for more accurate and rapid testing grows, the molecular methods market has expanded globally. The United States, China, Germany, India, and Japan are key players in this market, each contributing unique advancements and driving innovation in their respective regions. In this overview, we will explore the recent developments within these countries.

• United States: In the United States, molecular methods, particularly PCR (polymerase chain reaction) and next-generation sequencing (NGS), continue to lead to advancements in genetic testing, diagnostics, and personalized medicine. The COVID-19 pandemic significantly boosted the demand for molecular diagnostics, accelerating innovation in the development of rapid testing solutions. Furthermore, the integration of AI and machine learning in molecular diagnostics is gaining traction, enabling better data interpretation and faster diagnoses. The U.S. is also focusing on expanding research into CRISPR gene editing techniques, which will significantly impact various fields, including agriculture and healthcare.
• China: China is increasingly focusing on expanding its molecular method capabilities in both healthcare and agricultural sectors. The country has made significant strides in NGS and PCR technologies, particularly for the early detection of infectious diseases and genetic conditions. The Chinese government has also invested heavily in biotechnology research, aiming to improve diagnostics and healthcare infrastructure. Additionally, China is leading efforts to develop molecular methods for agricultural applications, including the detection of plant pathogens and the development of genetically modified crops, which could further boost food security and sustainability.
• Germany: Germany is at the forefront of applying molecular methods in diagnostics and research, with significant contributions to PCR and NGS technologies. The country’s strong biotech industry is driving innovations in molecular diagnostics, particularly in oncology and infectious diseases. Researchers in Germany are developing cutting-edge molecular tools to detect genetic mutations and markers associated with various cancers, enabling earlier detection and more effective treatments. Germany is also focusing on expanding its research in molecular biology for agricultural uses, including the development of sustainable farming practices through molecular methods.
• India: The Indian molecular methods market is rapidly evolving, driven by the need for affordable diagnostic solutions and advancements in biotechnology. PCR technology is widely used for diagnosing infectious diseases, including tuberculosis and COVID-19. However, India still faces challenges with access to high-quality molecular diagnostic tools in rural areas. Efforts are being made to develop more cost-effective molecular testing platforms and expand access across the country. India is also focusing on the research and development of molecular methods for improving crop yield and pest management in agriculture.
• Japan: Japan remains a leader in molecular research, particularly in healthcare and agriculture. The country is heavily investing in advancements in molecular diagnostic tools for early detection of diseases like cancer, Alzheimer’s, and cardiovascular diseases. Japan’s molecular biology research is advancing the use of gene-editing tools such as CRISPR-Cas9. Additionally, the country is making strides in molecular methods for enhancing food security by developing more robust crops and improving food safety through pathogen detection technologies. Japan’s continued investments in biotechnology ensure its leadership in innovation of molecular methods.

Features of the Global Molecular Method Market

• Market Size Estimates: Molecular method market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Molecular method market size by type, application, and region in terms of value ($B).
• Regional Analysis: Molecular method market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the molecular method market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the molecular method market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the molecular method market by type (polymerase chain reaction (PCR), immunoassay, biosensors, microarray, and other), application (instrument, reagents & consumables, and services), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?